Seeking Alpha

Warner Chilcott (WCRX -0.9%) says a federal appeals court has vacated a lower court's ruling...

Warner Chilcott (WCRX -0.9%) says a federal appeals court has vacated a lower court's ruling that would have prevented Mylan (MYL +0.6%) from releasing a generic version of its Doryx acne drug until pending patent litigation was decided. The company says it will still vigorously defend its Doryx patent and intends to seek a new restraining order from the district court.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|